Interprofessional collaboration is key to treatment optimization when managing advanced and metastatic forms of non-melanoma skin cancer (NMSC). This activity is a Q&A interview series with 6 multidisciplinary and interprofessional experts on immunotherapy in NMSC. Listen as they describe how they, as oncologists, dermatologists, nurses, and PAs work with their healthcare teams to integrate immunotherapy into their practice to help improve outcomes for patients with advanced/metastatic NMSC.
Upon completion of this activity, participants should be better able to:
Director, Melanoma and Renal Cancer Team
Seattle Cancer Care Alliance
Associate Professor, Division of Medical Oncology
University of Washington School of Medicine
Associate Professor, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, WA
Physician Assistant, Seattle Cancer Care Alliance
Teaching Associate, University of Washington School of Medicine
Physician Assistant, UW Medicine
Seattle, WA
Medical Oncologist and Dermatologist
Massachusetts General Hospital
Director, Center for Merkel Cell Carcinoma
Co-Director, NMSC Multi-Disciplinary Clinic
Department of Medicine, Division of Hematology/Oncology
Department of Dermatology
Massachusetts General Cancer Center
Boston, MA
Director, Cutaneous Oncology, GW Cancer Center
Director, Dermatologic Surgery, GW Department of Dermatology
Associate Professor, Dermatology & Hematology/Oncology
George Washington University School of Medicine & Health
Washington, DC
Nurse Practitioner, Center for Melanoma
Massachusetts General Hospital
Boston, MA
Academic Director, Mohs Dermatologic Surgery Center
Director, Dana Farber High Risk Cancer Clinic
Assistant Professor, Dermatology, Harvard Medical School
Department of Dermatology Brigham and Women’s Faulkner Hospital
Boston, MA
Featured RMEI CE Activities
Stay up to date with the latest RMEI CE Activities and receive Exclusive Medical Education Resources
